Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Congressional Bill Would Restrict Pay-To-Delay Agreements
Pharmalot
Monday, December 16, 2013 - 2:19pm
tags:
pay-for-delay
Amarin CEO to Step Down; Replacement Named
Motley Fool
Monday, December 16, 2013 - 2:18pm
tags:
Amarin, Pharma CEOs, Joseph Zakrzewski
Possible New Lease On Life For Two Cardiology Drugs From Merck And J&J
Forbes
Monday, December 16, 2013 - 2:16pm
tags:
Merck, JNJ, Zontivity, Vorapaxar, Xarelto
Supreme Court refuses to hear ex-InterMune CEO's appeal
Yahoo/Reuters
Monday, December 16, 2013 - 2:14pm
tags:
Supreme Court, InterMune, Actimmune
Cubist antibiotic succeeds in late-stage trial, shares rise
Reuters
Monday, December 16, 2013 - 9:02am
tags:
ceftolozane/tazobactam, Cubist, antibiotics, intra-abdominal infections
J&J's combo diabetes drug held up by FDA
PM Live
Monday, December 16, 2013 - 8:29am
tags:
canagliflozin, diabetes, JNJ, metformin, FDA, Invokana
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Yahoo
Monday, December 16, 2013 - 8:24am
tags:
Valeant Pharmaceuticals, Solta Medical, devices, M&A
The Curious Case Of Questcor Pharmaceuticals
Seeking Alpha
Monday, December 16, 2013 - 8:22am
tags:
Questcor Pharmaceuticals, H.P. Acthar Gel
Opexa Therapeutics provides update on Phase IIb trial
Yahoo/Fly on the Wall
Monday, December 16, 2013 - 8:21am
tags:
Opexa, Tcelna, multiple sclerosis, MS
3 Bold Predictions for Keryx Biopharmaceuticals in 2014
Motley Fool
Monday, December 16, 2013 - 8:13am
tags:
Keryx, chronic kidney disease, Zerenex
[video]The Biggest Victims of the Patent Cliff in 2014
Motley Fool
Monday, December 16, 2013 - 8:11am
tags:
patents, AstraZeneca, Eli Lilly, Cymbalta, Nexium
Siemens, Pfizer to cooperate on diagnostic tests
Reuters
Monday, December 16, 2013 - 8:08am
tags:
Siemens, Pfizer, diagnostics
Lundbeck says to launch new Alzheimer drug in 2017
Reuters
Monday, December 16, 2013 - 8:07am
tags:
Lundbeck, Alzheimer's disease, Lu AE58054
Ziopharm: Finally A Winner In The War On Cancer?
Seeking Alpha
Monday, December 16, 2013 - 8:06am
tags:
Ziopharm, cancer, AbbVie, Amgen, Celgene, Celldex Therapeutics, Gilead Sciences, Immunogen, JNJ, ImmunoCellular Therapeutics, Pharmacyclics, Intrexon, Seattle Genetics
Will Recent Headlines Take Merck Higher?
Wall St Cheat Sheet
Monday, December 16, 2013 - 7:41am
tags:
Merck, MK-8931
GlaxoSmithKline plc Makes £629m Indian Investment
Motley Fool, UK
Monday, December 16, 2013 - 7:39am
tags:
GSK, India, M&A
Endo to Acquire Specialty Pharmaceutical Company NuPathe
Yahoo
Monday, December 16, 2013 - 7:37am
tags:
M&A, NuPathe, Endo Health Solutions
Positive Phase 2 Results from Agenus’ Brain Cancer Vaccine Published in Neuro-Oncology
Yahoo
Monday, December 16, 2013 - 7:35am
tags:
Agenus, glioblastoma multiforme, vaccines
ImmunoCellular: Post Hoc Analysis Of Disappointing Phase II Trial Of ICT-107
Seeking Alpha
Monday, December 16, 2013 - 7:32am
tags:
ICT-107, ImmunoCellular, Northwest Biotherapeutics
Report: Johnson & Johnson Has $4B Bids for Ortho Clinical
Wall St Cheat Sheet
Sunday, December 15, 2013 - 12:48pm
tags:
JNJ, Ortho Clinical Diagnostics, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.